Previous close | 7.52 |
Open | 7.46 |
Bid | 7.40 x 100 |
Ask | 7.49 x 200 |
Day's range | 7.40 - 7.64 |
52-week range | 5.99 - 12.90 |
Volume | |
Avg. volume | 202,911 |
Market cap | 370.088M |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The mean of analysts' price targets for Aura Biosciences (AURA) points to a 162.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Insights into Aura's Financial Health and Strategic Progress in Clinical Trials
Insiders were net buyers of Aura Biosciences, Inc.'s ( NASDAQ:AURA ) stock during the past year. That is, insiders...